352 related articles for article (PubMed ID: 11336587)
1. Linezolid--a review of the first oxazolidinone.
Norrby R
Expert Opin Pharmacother; 2001 Feb; 2(2):293-302. PubMed ID: 11336587
[TBL] [Abstract][Full Text] [Related]
2. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic.
Corti G; Cinelli R; Paradisi F
Int J Antimicrob Agents; 2000 Dec; 16(4):527-30. PubMed ID: 11118873
[TBL] [Abstract][Full Text] [Related]
3. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
[TBL] [Abstract][Full Text] [Related]
4. Linezolid: a review of its use in the management of serious gram-positive infections.
Perry CM; Jarvis B
Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
[TBL] [Abstract][Full Text] [Related]
5. Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.
Falagas ME; Vardakas KZ
Drug Saf; 2008; 31(9):753-68. PubMed ID: 18707190
[TBL] [Abstract][Full Text] [Related]
6. Linezolid.
Narang M; Gomber S
Indian Pediatr; 2004 Nov; 41(11):1129-32. PubMed ID: 15591662
[TBL] [Abstract][Full Text] [Related]
7. Linezolid for the treatment of resistant gram-positive cocci.
Bain KT; Wittbrodt ET
Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
[TBL] [Abstract][Full Text] [Related]
8. Tedizolid: a new oxazolidinone antimicrobial.
Kisgen JJ; Mansour H; Unger NR; Childs LM
Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
[TBL] [Abstract][Full Text] [Related]
9. Association of pharmacokinetic and pharmacodynamic aspects of linezolid with infection outcome.
Vardakas KZ; Kioumis I; Falagas ME
Curr Drug Metab; 2009 Jan; 10(1):2-12. PubMed ID: 19149508
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of linezolid in children.
Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
[TBL] [Abstract][Full Text] [Related]
11. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
12. Linezolid: the first oxazolidinone antimicrobial.
Moellering RC
Ann Intern Med; 2003 Jan; 138(2):135-42. PubMed ID: 12529096
[TBL] [Abstract][Full Text] [Related]
13. Linezolid: in infants and children with severe Gram-positive infections.
Lyseng-Williamson KA; Goa KL
Paediatr Drugs; 2003; 5(6):419-29; discussion 430-1. PubMed ID: 12765493
[TBL] [Abstract][Full Text] [Related]
14. The oxazolidinones as a new family of antimicrobial agent.
Marchese A; Schito GC
Clin Microbiol Infect; 2001; 7 Suppl 4():66-74. PubMed ID: 11688536
[TBL] [Abstract][Full Text] [Related]
15. Linezolid: an oxazolidinone antimicrobial agent.
Fung HB; Kirschenbaum HL; Ojofeitimi BO
Clin Ther; 2001 Mar; 23(3):356-91. PubMed ID: 11318073
[TBL] [Abstract][Full Text] [Related]
16. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
[TBL] [Abstract][Full Text] [Related]
17. Linezolid: pharmacokinetic characteristics and clinical studies.
Bouza E; Muñoz P
Clin Microbiol Infect; 2001; 7 Suppl 4():75-82. PubMed ID: 11688537
[TBL] [Abstract][Full Text] [Related]
18. Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies.
Rubinstein E; Isturiz R; Standiford HC; Smith LG; Oliphant TH; Cammarata S; Hafkin B; Le V; Remington J
Antimicrob Agents Chemother; 2003 Jun; 47(6):1824-31. PubMed ID: 12760854
[TBL] [Abstract][Full Text] [Related]
19. [Linezolid, an agent from a new class of antibiotics].
Kuijper EJ; Schippers EF; Bernards AT
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of linezolid in the treatment of skin and soft tissue infections.
Hau T
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):491-8. PubMed ID: 12172739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]